KMO
-
Prominent Huntington's disease researcher "fabricated data" in grant applications
Noted Huntington's disease researcher found to have falsified data on grant applications – but published findings sta
-
KMO inhibitor drug improves lifespan of Huntington's disease mice
Positive results from tests of a new 'KMO inhibiting' drug in Huntington's disease mice
-
CHDI Report: Day 3
Day 3 of CHDI’s HD therapeutics conference: growth factors and CHDI’s advanced therapies